The prognosis of rheumatoid arthritis: assessment of disease activity and disease severity in the clinic (Q41696444)

7 October 2017

1 reference

title

The prognosis of rheumatoid arthritis: assessment of disease activity and disease severity in the clinic (English)

1 reference

7 October 2017

1 reference

F Wolfe

1

1 reference

7 October 2017

language of work or name

English

0 references

publication date

1 December 1997

1 reference

American Journal of Medicine

7 October 2017

published in

1 reference

7 October 2017

volume

103

1 reference

7 October 2017

issue

6A

1 reference

7 October 2017

page(s)

12S-18S

1 reference

Measurement of patient outcome in arthritis

7 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

Associations of HLA-DRB and -DQB genes with two and five year outcome in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

Which traditional measures should be used in rheumatoid arthritis clinical trials?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

Reduced joint counts in controlled clinical trials in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

A simplified twenty-eight-joint quantitative articular index in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

Reduced joint counts in rheumatoid arthritis clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

Reduced joint count indices in the evaluation of rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

A self-administered rheumatoid arthritis disease activity index (RADAI) for epidemiologic research. Psychometric properties and correlation with parameters of disease activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

Comparison of the validity and reliability of self-reported articular indices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

The rapid assessment of disease activity in rheumatology (radar) questionnaire. Validity and sensitivity to change of a patient self-report measure of joint count and clinical status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

The assessment of disease activity in rheumatoid arthritis using a multivariate analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

Comparison of auranofin and aurothioglucose in the treatment of rheumatoid arthritis: a single blind study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

The mortality of rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

Prediction of long-term mortality in patients with rheumatoid arthritis according to simple questionnaire and joint count measures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

Formal education as a marker for increased mortality and morbidity in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

Work disability in early rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

Predictors of work disability in rheumatoid arthritis patients. A five-year followup

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

Identification of work disability in rheumatoid arthritis: physical, radiographic and laboratory variables do not add explanatory power to demographic and functional variables

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

Work disability among women with rheumatoid arthritis. The relative importance of disease, social, work, and family factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

Prognosis of functional capacity and work capacity in rheumatoid arthritis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

Work disability in rheumatoid arthritis: effects of disease, social, and work factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

The long-term outcomes of rheumatoid arthritis: a 23-year prospective, longitudinal study of total joint replacement and its predictors in 1,600 patients with rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

A multicenter study of annual health service utilization and costs in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

Prediction of progression of radiologic damage in newly diagnosed rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

Rheumatoid arthritis: treatment which controls the C-reactive protein and erythrocyte sedimentation rate reduces radiological progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

Rheumatoid arthritis: relation of serum C-reactive protein and erythrocyte sedimentation rates to radiographic changes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

The acute-phase response in relation to radiographic progression in early rheumatoid arthritis: a prospective study during the first three years of the disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2990003-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(97)90003-6

1 reference

7 October 2017

1 reference